Table 4.
Follow-up of Positive Screens of Either Type
| Screening Round | |||||
|---|---|---|---|---|---|
| T0 | T1 | T2 | T3 | ||
| Screened | N | 28,746 | 27,541 | 26,584 | 25,423 |
| Positive | N | 1,675 | 1,341 | 1,224 | 1,148 |
| % of Screened | 5.8 | 4.9 | 4.6 | 4.5 | |
| Biopsies | N | 566 | 264 | 182 | 158 |
| % of Positive | 33.8 | 19.7 | 14.9 | 13.8 | |
| Neoplasms * | N | 27 | 17 | 15 | 15 |
| % of Biopsies | 4.8 | 6.4 | 8.2 | 9.5 | |
| % of Pos (PPV) | 1.6 | 1.3 | 1.2 | 1.3 | |
| Yield per 10,000 Screened | 9.3 | 6.1 | 5.6 | 5.9 | |
| Invasive Cancers (ovarian or peritoneal) | N | 18 | 13 | 14 | 15 |
| % of Biopsies | 3.2 | 4.9 | 7.7 | 9.5 | |
| % of Pos (PPV) | 1.1 | 1.0 | 1.1 | 1.3 | |
| Yield per 10,000 Screened | 6.2 | 4.7 | 5.2 | 5.9 | |
*
Includes invasive cancers and LMPs (ovarian cancers of limited malignant potential).